Skinbiotherapeutics【SBTX】銘柄情報

Skinbiotherapeutics Plc (SBTX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

10.25

( -2.38% )

買値

10.00

売値

10.50

出来高

7,777

平均取引量 (3 か月)

1,008,226p

財務取引量

10.25 日の範囲 10.50

5.20 52 週間の範囲 22.50

時価総額

26.565M

企業価値

25.027M

前日終値

10.50

始値

10.50

時刻

10.0025

(O)

最終取引時間

VWAP

歳入

5.23M

純利益

-456.41k

発行済株式数

259,168,671

浮動株比率 (%)

55.40%

機関投資家保有比率 (%)

59.68%

配当利回り

PER

-56.54

株価売上高倍率 (PSR)

5.21

1 株当たり利益 (EPS)

-0

ベータ

0.11

SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome ... SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome to promote wound healing and reduce the risk of infection; AxisBiotix-Ps, which alleviate the symptoms associate with psoriasis; and MediBiotix, CleanBiotix, and PharmaBiotix which are in early stages of development. The company has an agreement with Croda Plc for the development of SkinBiotix as an active ingredient for the skicare and cosmetic industry. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom. 詳細を表示

セクター

Health Care

業界

ウェブサイト

www.skinbiotherapeutics.com

本社

Newcastle Upon Tyne, United Kingdom

設立

2026

Skinbiotherapeutics Plc is listed in the Health Care sector of the ロンドン証券取引所 with ticker SBTX. The last closing price for Skinbiotherapeutics was 10.50p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 5.20p to 22.50p.

Skinbiotherapeutics currently has 259,168,671 shares in issue. The market capitalisation of Skinbiotherapeutics is £26.56 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -56.54.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.25	-2.38095238095	10.5	10.5	10.25	80634	10.5	DE
4	3.75	57.6923076923	6.5	13.25	6.5	758892	10.70469416	DE
12	2.25	28.125	8	13.25	6.25	893903	9.97839779	DE
26	-11.25	-52.3255813953	21.5	22.5	5.2	3796978	10.43639512	DE
52	-6.5	-38.8059701493	16.75	22.5	5.2	2067430	11.84927683	DE
156	-1.875	-15.4639175258	12.125	29.5	5.2	1256356	13.93302366	DE
260	-51.75	-83.4677419355	62	77.5	5.2	918444	18.36777793	DE